PER 1.39% 7.1¢ percheron therapeutics limited

Research note, page-99

  1. 1,067 Posts.
    lightbulb Created with Sketch. 498
    Thanks again for this!

    The "likely" phase IIb trial details are interesting:
    • 35 on placebo
    • 35 on 25mg (same as phase IIa)
    • 35 on unspecified dose

    Would anyone happen have an idea as to whether the "unspecified dose" group is likely to be varied, or fixed?
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.1¢
Change
-0.001(1.39%)
Mkt cap ! $64.00M
Open High Low Value Volume
7.3¢ 7.3¢ 7.0¢ $49.49K 694.4K

Buyers (Bids)

No. Vol. Price($)
2 80000 7.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.3¢ 178000 2
View Market Depth
Last trade - 14.55pm 01/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.